维普期刊资源整合服务平台（V6.5）

2473篇 您的检索式：期刊名="Risk Management"

选中清除导出查看参考文献查看引证文献引用追踪共124页首页上一页第1页下一页末页 /124 跳转

	题名	作者	年代	出处	被引量
1	Weight neutrality with the DPP-4 inhibitor, vildagliptin: Mechanistic basis and clinical experience显示文摘	James Foley	2010	Vascular Health and Risk Management (default)2010，，：	3
2	Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil显示文摘	Mason	2011	Vascular Health and Risk Management (default)2011，，：	2
3	Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans显示文摘	Benjamin Longo-Mbenza Gombet Mokondjimobe Nkondi Mbungu Vangu Ellenga-Mbolla Ibara	2012	Vascular Health and Risk Management (default)2012，，：	2
4	Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol显示文摘	Huynh PN Scott LG Kwong KYC	2010	Ther Clin Risk Manag2010，6，：	1
5	Low high density lipo- protein cholesterol: current status and future strategies for management 显示文摘	Singh V Sharma R Kumar A	2010	Vasc Health Risk Manag2010，6，2：	1
6	Optimal management of familial hypercholesterolemia: treatment and management strate- gies显示文摘	Mohammad Hassan Nemati Behrooz Astaneh	2010	Vase Health Risk Manag2010，6，：	1
7	Update on dexmedetomidine:use in nonintubated patients requiring sedation for surgical procedures显示文摘	Shukry M Miller JA	2010	Ther Clin Risk Manag2010，6，4：	1
8	Life Cycle Design of Milk and Juice Packaging显示文摘	SPITZLEY D V KEOLEIAN G A MCDANIEL J S	1997	National Risk Management Research Laboratory Cincinnat-i1997，，8：	1
9	Natriuretic peptides(BNPand NT-proBNP):measurement and relevance in heart failure显示文摘	Palazzuoli A Gallotta M Quatrini I	2010	VascHealth Risk Manag2010，6，：	1
10	Early detection and management of the high-risk patient with elevated blood pressure 显示文摘	Sierra C de la Sierra A	2008	Vase Health Risk Manag2008，4，2：	1
11	Treatment of pruritic diseases with topical calcineurin inhibitors显示文摘	Stander S Schurmeyer-Horst F Luger TA	2006	Ther Clin Risk Manag2006，2，：	1
12	Management of Age-Related Osteoporosis and Prevention of Associated Fractures显示文摘	Eric J MacLaughlin Rebecca B Sleeper Danny McNatty	2006	Ther Clin Risk Manag2006，2，3：	1
13	Novel antiplatelet a- gents in the prevention of cardiovascular complications-- focus on ticagrelor显示文摘	Marezewski MM Postula M Kosior D	2010	Vase Health Risk Manag2010，6，：	1
14	Pemetrexed as first-linetherapy for non-squamous non-small cell lung cancer显示文摘	Ricciardi S Tomao S de Marinis F	2009	TherClin Risk Manag2009，5，：	1
15	Atorvastatin in stroke: a review of SPARCL and subgroup analysis 显示文摘	Huisa BN Stemer AB Zivin JA	2010	Vasc Health Risk Manag2010，6，：	1
16	Palonosetron as an anti-emetic and anti-nausea agent in oncology显示文摘	Aapro MS	2007	Ther Clin Risk Manag2007，3，6：	1
17	Actual preoperative fasting time in Brazilian hospitals:The Bigfast multicenter study 显示文摘	Aguilar - Naseimento JE Almeida Dias AL Dock - Nascimento DB	2014	Therap Clini Risk Manag2014，10，1：	1
18	Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience显示文摘	Foley JE Jordan J	2010	Vasc Health Risk Manag2010，6，3：	1
19	Pre-eclampsia: pathophysiology, diagnosis, and management显示文摘	Ayoubi	2011	Vascular Health and Risk Management (default)2011，，：	1
20	Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aor- ta显示文摘	Xue YL Shi HX Murad F	2011	Vasc Health Risk Manag2011，7，：	1

返回顶部每页显示：

共124页首页上一页第1页下一页末页 /124 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示